6 research outputs found

    Extensive In Silico Analysis of ATL1 Gene : Discovered Five Mutations That May Cause Hereditary Spastic Paraplegia Type 3A

    No full text
    Background. Hereditary spastic paraplegia type 3A (SPG3A) is a neurodegenerative disease inherited type of Hereditary spastic paraplegia (HSP). It is the second most frequent type of HSP which is characterized by progressive bilateral and mostly symmetric spasticity and weakness of the legs. SPG3A gene mutations and the phenotype-genotype correlations have not yet been recognized. The aim of this work was to categorize the most damaging SNPs in ATL1 gene and to predict their impact on the functional and structural levels by several computational analysis tools. Methods. The raw data of ATL1 gene were retrieved from dbSNP database and then run into numerous computational analysis tools. Additionally; we submitted the common six deleterious outcomes from the previous functional analysis tools to I-mutant 3.0 and MUPro, respectively, to investigate their effect on the structural level. The 3D structure of ATL1 was predicted by RaptorX and modeled using UCSF Chimera to compare the differences between the native and the mutant amino acids. Results. Five nsSNPs out of 249 were classified as the most deleterious (rs746927118, rs979765709, rs119476049, rs864622269, and rs1242753115). Conclusions. In this study, the impact of nsSNPs in the ATL1 gene was investigated by various in silico tools that revealed five nsSNPs (V67F, T120I, R217Q, R495W, and G504E) are deleterious SNPs, which have a functional impact on ATL1 protein and, therefore, can be used as genomic biomarkers specifically before 4 years of age; also, it may play a key role in pharmacogenomics by evaluating drug response for this disabling disease

    Novel Mutations within PRSS1 Gene that Could Potentially Cause Hereditary Pancreatitis: Using Bioinformatics Approach

    Get PDF
    Hereditary pancreatitis (HP) is a rare heterogeneous disease with partial penetrance identified by frequent episodes of severe abdominal pain, often showing in young aged children. It is complicating by chronic pancreatitis, and high rate of pancreatic cancer (up to 40-50%). The aim of this work was to classify the most deleterious mutation in PRSS1 gene and to predict their influence on the functional and structural level by a variety of bioinformatics analysis tools. The raw data of PRSS1 gene were recovered from SNP database, and further used to examine a deleterious effect using SIFT, PolyPhen-2, PROVEAN, SNAP2, SNPs&GO, PHD-SNP, PANTHER and P-Mut. The functional analysis predicted that two SNPs “rs1366278558 and rs767036052” have a deleterious effect at functional level. Additionally, we submitted them to I-mutant 3.0, and MUPro respectively to investigate their effect on structural level; the two tools revealed that; two mutations have a dramatic decrease of the protein stability, thus suggesting that the M1R and L4P mutations of PRSS1  gene could destabilize the amino acid interactions causing functional abnormalities of PRSS1 protein. The 3D structure of PRSS1 was predicted by RaptorX and modeled using UCSF Chimera to compare the differences between the native and the mutant amino acids. From the comparative analysis at the functional and structural level, these two SNPs “M1R and L4P” have a deleterious effect and thus could be used as diagnostic markers to predict HP. These findings can be used as a platform to develop large-scale studies in the future

    Identification of Novel Key Biomarkers in Simpson-Golabi-Behmel Syndrome (SGBS): Evidence from Bioinformatics Analysis

    Get PDF
    The Simpson-Golabi-Behmel Syndrome (SGBS) or overgrowth Syndrome is an uncommon genetic X-linked disorder highlighted by macrosomia, renal defects, cardiac weaknesses and skeletal abnormalities. The purpose of the work was to classify the functional nsSNPs of GPC3 to serve as genetic biomarkers for overgrowth syndrome. The raw data of GPC3 gene were retrieved from dbSNP database and used to examine the most damaging effect using eight functional analysis tools, while we used I-mutant and MUPro to examine the effect of SNPs on GPC3 protein structure; The 3D structure of GPC3 protein is not found in the PDB, so RaptorX was used to create a 3D structural prototype to visualize the amino acids alterations by UCSF Chimera; For biophysical validation we used project HOPE; Lastly we run conservational analysis by BioEdit and Consurf web server respectively. Our results revealed three novel missense mutations (rs1460413167, rs1295603457 and rs757475450) that are that are more likely to be responsible for disturbance in the function and structure of GPC3. This work provides new insight into the molecular basis of overgrowth Syndrome by evidence from bioinformatics analysis. Three novel missense mutations (rs757475450, rs1295603457 and rs1460413167) are more likely to be responsible for disturbance in the function and structure of GPC3; therefore, they may be assisting as genetic biomarkers for overgrowth syndrome. As well as these SNPs can be used for the larger population-based studies of overgrowth syndrome

    Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach

    No full text
    BACKGROUND: A new endemic disease has spread across Wuhan City, China, in December 2019. Within few weeks, the World Health Organization (WHO) announced a novel coronavirus designated as coronavirus disease 2019 (COVID-19). In late January 2020, WHO declared the outbreak of a “public-health emergency of international concern” due to the rapid and increasing spread of the disease worldwide. Currently, there is no vaccine or approved treatment for this emerging infection; thus, the objective of this study is to design a multiepitope peptide vaccine against COVID-19 using an immunoinformatics approach. METHOD: everal techniques facilitating the combination of the immunoinformatics approach and comparative genomic approach were used in order to determine the potential peptides for designing the T-cell epitope-based peptide vaccine using the envelope protein of 2019-nCoV as a target. RESULTS: Extensive mutations, insertion, and deletion were discovered with comparative sequencing in the COVID-19 strain. Additionally, ten peptides binding to MHC class I and MHC class II were found to be promising candidates for vaccine design with adequate world population coverage of 88.5% and 99.99%, respectively. CONCLUSION: The T-cell epitope-based peptide vaccine was designed for COVID-19 using the envelope protein as an immunogenic target. Nevertheless, the proposed vaccine rapidly needs to be validated clinically in order to ensure its safety and immunogenic profile to help stop this epidemic before it leads to devastating global outbreaks

    Epitope-Based Peptide Vaccine against Glycoprotein G of Nipah Henipavirus Using Immunoinformatics Approaches

    No full text
    Background. Nipah belongs to the genusHenipavirusand theParamyxoviridae family. It is an endemic most commonly foundat South Asia and hasfirst emerged in Malaysia in 1998. Bats are found to be the main reservoir for this virus, causing disease inboth humans and animals. The last outbreak has occurred in May 2018 in Kerala. It is characterized by high pathogenicity andfatality rates which varies from 40% to 70% depending on the severity of the disease and on the availability of adequatehealthcare facilities. Currently, there are no antiviral drugs available for NiV disease and the treatment is just supportive.Clinical presentations for this virus range from asymptomatic infection to fatal encephalitis.Objective. This study is aimed atpredicting an effective epitope-based vaccine against glycoprotein G of Nipah henipavirus, using immunoinformaticsapproaches.Methods and Materials. Glycoprotein G of the Nipah virus sequence was retrieved from NCBI. Differentprediction tools were used to analyze the epitopes, namely, BepiPred-2.0: Sequential B Cell Epitope Predictor for B cell andT cell MHC classes II and I. Then, the proposed peptides were docked using Autodock 4.0 software program.Results andConclusions. The two peptides TVYHCSAVY and FLIDRINWI have showed a very strong binding affinity to MHC class Iand MHC class II alleles. Furthermore, considering the conservancy, the affinity, and the population coverage, the peptideFLIDRINWIT is highly suitable to be utilized to formulate a new vaccine against glycoprotein G of Nipah henipavirus. Anin vivo study for the proposed peptides is also highly recommended

    Epitope-Based Peptide Vaccine against Glycoprotein G of Nipah Henipavirus Using Immunoinformatics Approaches

    No full text
    Background. Nipah belongs to the genus Henipavirus and the Paramyxoviridae family. It is an endemic most commonly found at South Asia and has first emerged in Malaysia in 1998. Bats are found to be the main reservoir for this virus, causing disease in both humans and animals. The last outbreak has occurred in May 2018 in Kerala. It is characterized by high pathogenicity and fatality rates which varies from 40% to 70% depending on the severity of the disease and on the availability of adequate healthcare facilities. Currently, there are no antiviral drugs available for NiV disease and the treatment is just supportive. Clinical presentations for this virus range from asymptomatic infection to fatal encephalitis. Objective. This study is aimed at predicting an effective epitope-based vaccine against glycoprotein G of Nipah henipavirus, using immunoinformatics approaches. Methods and Materials. Glycoprotein G of the Nipah virus sequence was retrieved from NCBI. Different prediction tools were used to analyze the epitopes, namely, BepiPred-2.0: Sequential B Cell Epitope Predictor for B cell and T cell MHC classes II and I. Then, the proposed peptides were docked using Autodock 4.0 software program. Results and Conclusions. The two peptides TVYHCSAVY and FLIDRINWI have showed a very strong binding affinity to MHC class I and MHC class II alleles. Furthermore, considering the conservancy, the affinity, and the population coverage, the peptide FLIDRINWIT is highly suitable to be utilized to formulate a new vaccine against glycoprotein G of Nipah henipavirus. An in vivo study for the proposed peptides is also highly recommended
    corecore